Consistent with previous prospective studies (Tworoger et al, 2004) and case–control studies summarised in a recent review (Tworoger and Hankinson, 2008), we found that PRL levels were unrelated to two factors reflecting progression, tumour size, and lymph node metastases. The gene discussed is PRL; the disease is neoplasm.